Permanent pacemakers capable of triggered ventricular stimulation were implanted in 28 patients with a history of sustained ventricular tachycardia or fibrillation. Noninvasive programmed ventricular stimulation was performed on 125 occasions during follow-up periods ranging from 1 to 25 months and was used to assess the efficacy of antiarrhythmic drug therapy, drug or dosage changes and left ventricular endocardial resection. Drug or dosage changes based on noninvasive programmed ventricular stimulation were made in 19 of the 28 patients. In addition, 126 episodes of spontaneous sustained ventricular tachycardia were terminated noninvasively in nine patients. It is concluded that a permanent pacemaker capable of triggered ventricular stimu...
Pacemakers are playing an increasing role in the management of patients with tachycardia. Pacing to ...
Sustained atrial tachycardias occurring after surgery for congenital heart disease, are often diffic...
A second-generation implantable pacemaker-cardioverter-defibrillator was evaluated in 200 patients w...
Permanent pacemakers capable of triggered ventricular stimulation were implanted in 28 patients with...
The use of an antitachycardia pacemaker for the treatment of recurrent, drug resistant nonsyncopal s...
Eleven patients with recurrent tachycardia refractory to drugs were treated by a pacemaker system th...
A patient with recurrent sustained ventricular tachycardia that was resistant to both conventional a...
Ten consecutive patients (mean age 57.9 +/- 7.6 years) were treated with an investigational tachyarr...
The Intermedics Intertach 262-12 tachycardia reversion pulse generator was implanted in 14 patients ...
It is now generally agreed that the presence of symptoms is an indication for long-term pacing of pa...
An automatic burst pacemaker (Cybertach-60) was used to treat drug-resistant recurrent ventricular t...
An antitachycardia pulse generator, the Intermedics Intertach 262-12 was implanted in 16 patients (1...
A new method for pacemaker treatment of refractory reentry tachycardias has been developed which in ...
This report describes the multicenter experience of the Tachylog antitachycardia pacemaker (Siemens-...
This paper reviews the mechanism of recurrent sustained ventricular tachycardia (VT) which have been...
Pacemakers are playing an increasing role in the management of patients with tachycardia. Pacing to ...
Sustained atrial tachycardias occurring after surgery for congenital heart disease, are often diffic...
A second-generation implantable pacemaker-cardioverter-defibrillator was evaluated in 200 patients w...
Permanent pacemakers capable of triggered ventricular stimulation were implanted in 28 patients with...
The use of an antitachycardia pacemaker for the treatment of recurrent, drug resistant nonsyncopal s...
Eleven patients with recurrent tachycardia refractory to drugs were treated by a pacemaker system th...
A patient with recurrent sustained ventricular tachycardia that was resistant to both conventional a...
Ten consecutive patients (mean age 57.9 +/- 7.6 years) were treated with an investigational tachyarr...
The Intermedics Intertach 262-12 tachycardia reversion pulse generator was implanted in 14 patients ...
It is now generally agreed that the presence of symptoms is an indication for long-term pacing of pa...
An automatic burst pacemaker (Cybertach-60) was used to treat drug-resistant recurrent ventricular t...
An antitachycardia pulse generator, the Intermedics Intertach 262-12 was implanted in 16 patients (1...
A new method for pacemaker treatment of refractory reentry tachycardias has been developed which in ...
This report describes the multicenter experience of the Tachylog antitachycardia pacemaker (Siemens-...
This paper reviews the mechanism of recurrent sustained ventricular tachycardia (VT) which have been...
Pacemakers are playing an increasing role in the management of patients with tachycardia. Pacing to ...
Sustained atrial tachycardias occurring after surgery for congenital heart disease, are often diffic...
A second-generation implantable pacemaker-cardioverter-defibrillator was evaluated in 200 patients w...